Skripsi
OPTIMASI FORMULA TABLET GASTRORETENTIVE EKSTRAK ETANOL DAUN SUKUN (Artocarpus altilis) DENGAN VARIASI KONJAC GLUCOMANNAN DAN NATRIUM BIKARBONAT MENGGUNAKAN DESAIN FAKTORIAL
Gastric ulcer is a mucosal disturbance of the stomach caused by an imbalance between aggressive and protective factors, which requires a drug delivery system that can enhance the effectiveness of therapy.Ethanol extract of breadfruit leaves (Artocarpus altilis) exhibits gastroprotective activity at a dose of 400 mg, but requires an optimal formulation. This study aims to optimize the formulation of breadfruit leaf ethanol extract tablets into a gastroretentive drug delivery system (GRDDS) to increase drug retention time in the stomach and control the drug release gradually. Optimization was performed using a 22 factorial design to evaluate the effect of variations in the concentration of konjac glucomannan (KGM) and sodium bicarbonate on the physical characteristics and drug release of the tablets. The tablets were made by wet granulation and evaluated for hardness, friability, floating lag time, floating time, drug content, dissolution, mucoadhesive time, stability, and FTIR analysis. The test results showed that the tablets had a hardness of 4.9–5.3 kgf, friability of 0.8–0.9%, a floating lag time of 54.33 ± 0.58 seconds, and a floating time of over 24 hours. The dissolution test showed controlled drug release, with 84.22% of the drug released within 12 hours, following zero-order release kinetics. The drug content test results showed a drug content of 93.04 ± 0.87%, with good content uniformity (NP 7.934 < L1). The mucoadhesive evaluation showed that the tablets could adhere to the gastric mucosa for 24 hours. FTIR analysis showed no significant chemical interaction between the breadfruit leaf extract, KGM, and sodium bicarbonate, indicating the stability of the formulation. The formulation stability was well maintained after 6 cycles at 4°C and 25°C. Based on the research results, the optimized formulation demonstrates an increase in the effectiveness of gastric ulcer therapy through controlled drug release, as evidenced by the dissolution test, which showed 84.22% drug release within 12 hours. This is also supported by a longer drug retention time in the stomach (more than 24 hours), which can prolong the duration of therapy and enhance the effectiveness of gastric ulcer treatment.
No other version available